TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Salipro Biotech AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
538
|
671
|
441 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-384
|
-216
|
-190 |
EBITDA |
-334
|
-166
|
-143 |
Total assets |
1,408
|
1,764
|
2,148 |
Current assets |
860
|
1,282
|
1,668 |
Current liabilities |
156
|
132
|
138 |
Equity capital |
1,252
|
1,631
|
2,010 |
- share capital |
6
![]() |
6
|
7 |
Employees (average) |
9
|
7
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
88.9%
|
92.5%
|
93.6% |
Turnover per employee |
60
|
96
|
74 |
Profit as a percentage of turnover |
-71.4%
|
-32.2%
|
-43.1% |
Return on assets (ROA) |
-27.3%
|
-12.2%
|
-8.8% |
Current ratio |
551.3%
|
971.2%
|
1208.7% |
Return on equity (ROE) |
-30.7%
|
-13.2%
|
-9.5% |
Change turnover |
-135
|
266
|
95 |
Change turnover % |
-20%
|
66%
|
28% |
Chg. No. of employees |
2
|
1
|
0 |
Chg. No. of employees % |
29%
|
17%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.